Lebwohl David

EVP, Chief Medical Officer at NTLA

Sold, on record
$2.4M
Dollars the filings state
Form 4 sales
10
Latest Jan 5, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • NTLAIntellia Therapeutics, Inc.EVP, Chief Medical Officer

Sales by reason

0
Routine
0
Plan not stated
1
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale NTLAUnusual
    Sep 21, 2021 2021

    Sold 2,400 shares at $149.81 ($360k)

    Lebwohl David, EVP, Chief Medical Officer

    Sold 75.2% of holdings ($478k position)791 shares leftFiling

  2. 2 Form 4 sale NTLAPlan not stated
    Oct 14, 2021 +23 days

    Sold 2,400 shares at $128.44 ($308k)

    Lebwohl David, EVP, Chief Medical Officer

    Sold 21.6% of holdings ($1.4M position)8,714 shares left1x usual sizeFiling

  3. 3 Form 4 sale NTLAPlan not stated
    Nov 5, 2021 +22 days

    Sold 2,400 shares at $132.72 ($319k)

    Lebwohl David, EVP, Chief Medical Officer

    Sold 21.6% of holdings ($1.5M position)8,714 shares left1x usual sizeFiling

  4. 4 Form 4 sale NTLAPlan not stated
    Jan 1, 2022 +57 days

    Sold 1,051 shares at $112.24 ($118k)

    Lebwohl David, EVP, Chief Medical Officer

    Sold 8.8% of holdings ($1.3M position)10,922 shares left0.4x usual sizeFiling

  5. 5 Form 4 sale NTLAPlan not stated
    Jan 4, 2023 +368 days

    Sold 2,574 shares at $37.21 ($96k)

    Lebwohl David, EVP, Chief Medical Officer

    Sold 9.1% of holdings ($1.1M position)25,687 shares left1.1x usual sizeFiling

  6. 6 Form 4 sale NTLANo plan
    Jan 3, 2024 +364 days

    Sold 5,843 shares at $29.46 ($172k)

    Lebwohl David, EVP, Chief Medical Officer

    No 10b5-1 planSold 9.7% of holdings ($1.8M position)54,372 shares leftFiling

  7. 7 Form 4 sale NTLANo plan
    Jan 3, 2025 +366 days

    Sold 9,557 shares at $12.18 ($116k)

    Lebwohl David, EVP, Chief Medical Officer

    No 10b5-1 planSold 9.8% of holdings ($1.2M position)87,666 shares leftFiling

  8. 8 Form 4 sale NTLANo plan
    Jan 5, 2026 +367 days

    Sold 11,903 shares at $9.21 ($110k)

    Lebwohl David, EVP, Chief Medical Officer

    No 10b5-1 planSold 8.9% of holdings ($1.2M position)121,249 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (10)

Form 144 notices and Form 4 sales by Lebwohl David
Source
Jan 5, 2026Jan 7, 2026NTLAEVP, Chief Medical OfficerForm 4 sale11,903$110k8.9%No planSEC
Jan 3, 2025Jan 7, 2025NTLAEVP, Chief Medical OfficerForm 4 sale9,557$116k9.8%No planSEC
Jan 3, 2024Jan 5, 2024NTLAEVP, Chief Medical OfficerForm 4 sale5,843$172k9.7%No planSEC
Jan 4, 2023Jan 6, 2023NTLAEVP, Chief Medical OfficerForm 4 sale2,574$96k9.1%Plan not statedSEC
Jan 1, 2022Mar 3, 2022NTLAEVP, Chief Medical OfficerForm 4 sale1,051$118k8.8%Plan not statedSEC
Nov 5, 2021Nov 9, 2021NTLAEVP, Chief Medical OfficerForm 4 sale2,400$319k21.6%Plan not statedSEC
Oct 14, 2021Oct 15, 2021NTLAEVP, Chief Medical OfficerForm 4 sale2,400$308k21.6%Plan not statedSEC
Sep 21, 2021Sep 23, 2021NTLAEVP, Chief Medical OfficerForm 4 sale2,400$360k75.2%UnusualSEC
Aug 30, 2021Sep 1, 2021NTLAEVP, Chief Medical OfficerForm 4 sale2,400$379k75.2%UnusualSEC
Aug 9, 2021Aug 11, 2021NTLAEVP, Chief Medical OfficerForm 4 sale2,400$394k75.2%UnusualSEC